Neocardio Diagnostics Private Limited
About Neocardio Diagnostics Private Limited
Data last updated:
Neocardio Diagnostics Private Limited was a private limited company based in Chennai, Tamil Nadu, India. The company has been converted to a Limited Liability Partnership (LLP) and no longer exists as a company. For the latest details, refer to the successor LLP. It operated in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 26 October 2017.
The company was registered with the Registrar of Companies (ROC), Chennai, under CIN U15100TN2017PTC119254. Its GSTIN is 33AAGCK8163R1ZU (Tamil Nadu).
The company had an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. It was formerly known as Ki&A Associates Private Limited.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office was at 3rd Floor Jhaver Plaza 1 – A Nungambakkam High Road, Chennai, Tamil Nadu, India – 600034.
As per the financials filed for FY 2019, the company reported a revenue of ₹6.16 Lakh. For the same year it recorded a net loss of ₹93.97 Lakh and EBITDA of -₹93.97 Lakh.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address3rd Floor Jhaver Plaza 1 – A Nungambakkam High Road, Chennai, Tamil Nadu, India – 600034
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Neocardio Diagnostics Private Limited FY 2019 filings available
Neocardio Diagnostics Private Limited reported revenue of ₹6.16 Lakh for FY 2019.
Financial Statement Summary of Neocardio Diagnostics Private Limited
| Metrics | FY 2018-19 | FY 2017-18 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | ₹6.16 Lakh | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | -₹93.97 Lakh | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | -₹93.97 Lakh | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Neocardio Diagnostics Private Limited
| Metrics | FY 2018-19 | FY 2017-18 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | •••• | •••• |
| Net Profit Margin | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Neocardio Diagnostics are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Neocardio Diagnostics Private Limited
Neocardio Diagnostics has 4 former directors on record and no current directors listed.
Peer Comparison of Neocardio Diagnostics Private Limited
Neocardio Diagnostics Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Neo Bacto Kidney Care Clinic Private Limited | ₹6.46 Lakh (FY 2025) | •••• | •••• | -34.0% | •••• | Kolkata, West Bengal, India |
| Subhlok Diagnostix Private Limited | ₹6.44 Lakh (FY 2023) | •••• | •••• | •••• | Dehradun, Uttarakhand, India | |
| SSRM Pathology Clinic Private Limited | ₹6.28 Lakh (FY 2025) | •••• | •••• | -79.0% | •••• | Kolkata, West Bengal, India |
| Perfect Health and Lifestyle Management Private Limited | ₹6.26 Lakh (FY 2025) | •••• | •••• | •••• | Nagapattinam, Tamil Nadu, India | |
| United Rise Path Lab Private Limited | ₹6.24 Lakh (FY 2020) | •••• | •••• | •••• | East Old Seelampur, Delhi, India | |
| Neocardio Diagnostics Private Limited this company | ₹6.16 Lakh (FY 2019) | •••• | •••• | •••• | Chennai, Tamil Nadu, India | |
| Nitson Laboratories Consultation Services Private Limited | ₹6.12 Lakh (FY 2025) | •••• | •••• | -28.0% | •••• | Mumbai, Maharashtra, India |
| Devadi Etechnologies Private Limited | ₹6.1 Lakh (FY 2025) | •••• | •••• | -34.0% | •••• | Gurgaon, Haryana, India |
| Health Line Medicare Private Limited | ₹6.01 Lakh (FY 2025) | •••• | •••• | -84.0% | •••• | Agra, Uttar Pradesh, India |
| Rohini C.T.Scan Centre Ltd | ₹5.82 Lakh (FY 2022) | •••• | •••• | 4.0% | •••• | Warangal, Telangana, India |
| Tunge Diagnostic Centre Private Limited | ₹5.65 Lakh (FY 2023) | •••• | •••• | -96.0% | •••• | Raichur, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Neocardio Diagnostics by revenue in the Healthcare industry (Diagnostics and Pathology Labs), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Neocardio Diagnostics Private Limited
Neocardio Diagnostics Private Limited is audited by P K F SRIDHAR & SANTHANAM LLP for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| P K F SRIDHAR & SANTHANAM LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Neocardio Diagnostics Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Neocardio Diagnostics Private Limited
Neocardio Diagnostics Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Neocardio Diagnostics Private Limited
Employment history and EPFO contributions of people linked to Neocardio Diagnostics.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Neocardio Diagnostics Private Limited
Neocardio Diagnostics Private Limited has 4 board changes on record since 2018: 0 appointments and 4 cessations. The latest: Fragkiskos Samaras ceased to be Director on 21 May 2020.
Credit Ratings, Litigation & Regulatory Alerts for Neocardio Diagnostics Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Neocardio Diagnostics Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Neocardio Diagnostics Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Neocardio Diagnostics Private Limited
Neocardio Diagnostics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAGCK8163R1ZU | Tamil Nadu | Active | 03 Apr 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Neocardio Diagnostics Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neocardio Diagnostics Private Limited
Neocardio Diagnostics has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.
Neocardio Diagnostics was a private limited company based in Chennai, Tamil Nadu, India. The company worked in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 26 October 2017 and is registered under CIN U15100TN2017PTC119254. For the latest details, refer to the successor LLP entity.
The CIN (Corporate Identification Number) of Neocardio Diagnostics is U15100TN2017PTC119254. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neocardio Diagnostics was incorporated on 26 October 2017. It is registered with the Registrar of Companies, Chennai.
The registered office of Neocardio Diagnostics is at 3rd Floor Jhaver Plaza 1 – A Nungambakkam High Road, Chennai, Tamil Nadu, India – 600034.
Neocardio Diagnostics reported revenue of ₹6.16 Lakh for FY 2019.
Neocardio Diagnostics has an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr.
Neocardio Diagnostics reported a net loss of ₹93.97 Lakh and EBITDA of -₹93.97 Lakh for FY 2019, as per its filed financial statements.
The GSTIN of Neocardio Diagnostics is 33AAGCK8163R1ZU, registered in Tamil Nadu.
Neocardio Diagnostics operated in the healthcare industry, in the diagnostic centers and pathology labs segment.
No. Neocardio Diagnostics is not listed on any stock exchange. It is an unlisted company.